Skip to main content

Pelvic Mesh $20M Verdict Slashed By $5M

Pelvic Mesh $20M Verdict Slashed By $5M

Pelvic Mesh $20M Verdict Slashed By $5M

Introduction

Johnson & Johnson (J&J) and its subsidiary Ethicon’s attempt to toss the $20 million pelvic mesh verdict was rejected by a Pennsylvania appellate court, but the court reduced the verdict to $15 million.

According to the pretrial memorandum, the plaintiff of Cinnaminson, New Jersey, had Ethicon’s TVT-Secur mesh implanted in June 2007 to help her with stress urinary incontinence. A couple of months later, her doctor discovered erosions in the material, which led to three separate surgeries to remove the material. However, she developed chronic pain and urinary dysfunction, as portions of the mesh remained in her body.

The plaintiff alleged stating that despite knowing there was a significant risk of mesh eroding inside patients, the manufacturers released the product to the public. The initial verdict was passed in April 2017, which included $2.5 million in compensatory damages, as well as $17.5 million in punitive damages.

The defendants appealed to toss the verdict, challenging the rules on the statute of limitations and several of the judge’s evidentiary rulings. On Friday, a split three-judge panel of the Superior Court reinstated the initial verdict, rejecting the appeal.

U.S. District Judge Joseph R. Goodwin is presiding over all Ethicon pelvic mesh lawsuits consolidated under multidistrict litigation (MDL No. 2327; In Re: Ethicon, Inc., Pelvic Repair System Products Liability Litigation) in the Southern District of West Virginia.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

NC to Get $150M to Boost Opioid Treatment, Recovery

Categories: Opioids

North Carolina will receive an additional $150 million from Purdue Pharma and the Sackler family as part of a national $7.4 billion settlement related to the opioid

SRI Gets FDA OK for High-Dose Naloxone Trial

Categories: Opioids

SRI has received authorization from the U.S. Food and Drug Administration (FDA) to begin Phase 1 clinical trials of a new, high-dose injectable naloxone formulation.

The approval was granted under an Investigational New Drug (IND)…

Spokane County to Get $5M in New Opioid Settlement

Categories: Opioids

Jurisdictions within Spokane County are set to receive nearly $4.7 million as part of a sweeping $7.4 billion nationwide settlement with Purdue Pharma and its owners, the Sackler family.

The agreement addresses the company’s role in fueling…

✍️ FREE—3000 Pages Medical Record Review Trial!                
No Contract. No Risk—Fully Customized, Free!

Only 10 Firms Accepted—Offer Ends June 30!